The transition from hyperplasia to invasive carcinoma of the breast.
about
Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancerE-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary typeNuclear cytometric changes in breast carcinogenesis.Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancerDeregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.ER81 Expression in Breast Cancers and HyperplasiaCystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.Endocrine-responsive breast cancer and strategies for combating resistance.A multistage association study identifies a breast cancer genetic locus at NCOA7.Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?Classification of ductal carcinoma in situ by gene expression profiling.Serum IGFBP-2 and Risk of Atypical Hyperplasia of the BreastLoss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomasPrecancerous Lesions of the BreastComparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancerTranscriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.Breast pathology practice: most common problems in a consultation service.Re-evaluating early breast neoplasia.Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27Expression of nm23 in the spectrum of pre-invasive, invasive and metastatic breast lesions.Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib.Estrogen plus progestin and risk of benign proliferative breast disease.Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.The infrared radiation temperature characteristic of acupoints of mammary gland hyperplasia patients.Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial.Molecular biology of breast tumor progression: a view from the other side.Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.Immunotherapy of cancer: reprogramming tumor-immune crosstalk.Pharmacodynamics and Medicinal Chemistry of an External Chinese Herbal Formula for Mammary Precancerous Lesions.Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest.Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
P2860
Q24535378-5A84B6C9-D723-4D8B-AD74-35E5133E9A8EQ24802136-9B1AAD6C-CA11-4658-9146-88317C5B0B6AQ28191099-DEE38EDB-A2F9-44AD-B34F-43DCD4EB68EFQ31909970-DD7A7485-A882-4BAC-8495-7ED5B3CA5750Q33295223-FFBA4F41-91B7-4BF1-A14C-FB64942356E3Q33685222-7987221F-36FE-4AF6-B74B-D2C708B85AA1Q33857846-14964A07-F277-4B49-9BAC-F8F0D2A803BEQ34272277-8A696175-1ED8-4112-A083-32C2EB58FF5AQ34580038-DC0D1E07-7F0B-418E-9FFD-58DB1E47780DQ34956077-12C6565F-7C57-4EF7-AD79-C17C26E1B6C1Q35083639-E456CDD4-BBB9-4219-BD0B-6BB0492F9BD8Q35084786-9262C2E3-A335-41A8-AF2F-D04DD2516AD0Q35108072-A701E1B7-3451-4068-B594-C3B1C68C8F4BQ35587486-2EB96313-3154-4084-9836-898E93843D79Q35605885-5224053E-772C-4995-8F93-797651217257Q35729809-8F9535A8-A9E6-4EBF-9DC8-8D559880E7E9Q35747471-64DFD031-A2C1-4D54-B411-6184D4BA06E6Q35940061-ECB118CF-4F6C-495C-8240-4E37E320D3D5Q36119454-76F85EC6-A9B6-4F27-AE6F-B7A7DB30B1F4Q36166126-1028DEB0-1571-4DBF-8594-7E4D6076C85FQ36284318-67C9E8D4-2C39-4307-9C45-07010E282880Q36293509-0F28A7FE-3DDF-4A20-B0D0-62543E400D9AQ36643056-B97BDEFE-C821-480D-A8E2-E15734A4687CQ36673759-A8A75F38-8C85-4854-9237-13653829A57AQ36711486-55865F8C-6A7A-43D3-A74F-568F24157772Q36958371-A997E44E-C1FF-4E63-A904-C1F357EF5CE5Q36976159-FE8FE414-62ED-4222-98D9-CA48BA3685BFQ37000452-A7AF14D4-1C22-435F-B1DB-12BEA34C4D80Q37293304-4466F34A-BC7F-46E4-8FDD-D03819EF0314Q37358319-71BEF321-DA46-414E-88C6-5ED6C057BEC7Q37363284-11DB8306-9EA5-4BA3-AB44-08527F3BE139Q37367067-86A052D3-53BB-4337-8927-4B3D50962782Q37756399-AC244874-1AF0-42E0-AFA8-DA1A4878FDCAQ38017089-387CF23E-11ED-4562-858D-BC53E873D487Q38055479-44E4A314-73EB-4F79-A760-D1A3C7A1B558Q38622858-B5B0567E-2AA8-4F7C-B480-C79F34E5DCD9Q38902230-F254599D-E750-4EFC-B3FB-16F217A3255EQ39443325-6C26B6B6-7055-464F-B5B4-EA74ACD038FAQ41346977-9EF31BCD-2DD5-418E-A77D-58EC381E43A6Q42514277-E724E802-576C-4DA3-A7A6-5EA212A95C63
P2860
The transition from hyperplasia to invasive carcinoma of the breast.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The transition from hyperplasia to invasive carcinoma of the breast.
@ast
The transition from hyperplasia to invasive carcinoma of the breast.
@en
type
label
The transition from hyperplasia to invasive carcinoma of the breast.
@ast
The transition from hyperplasia to invasive carcinoma of the breast.
@en
prefLabel
The transition from hyperplasia to invasive carcinoma of the breast.
@ast
The transition from hyperplasia to invasive carcinoma of the breast.
@en
P1476
The transition from hyperplasia to invasive carcinoma of the breast.
@en
P2093
Lakhani SR
P304
P356
10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2
P577
1999-02-01T00:00:00Z